Automated description from the Alliance of Genome Resources (Release 7.0.0)
Predicted to enable amyloid-beta binding activity and low-density lipoprotein particle receptor binding activity. Predicted to be involved in negative regulation of cell cycle phase transition; negative regulation of transcription by RNA polymerase II; and positive regulation of protein secretion. Predicted to act upstream of or within negative regulation of apoptotic process. Predicted to be located in several cellular components, including actin cytoskeleton; cytosol; and nuclear body. Predicted to be active in cytoplasm and nucleus. Orthologous to human APBB3 (amyloid beta precursor protein binding family B member 3).